Search

everythinglearnresearchcommunity

for

Search:↓

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Upadacitinib improved multiple immune-related conditions in one patient.

MVP treatment is effective and safe for recurrent breast cancer.

ABCG2 protein marks stem-like skin cells in human epidermis.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Deucravacitinib helped a man regrow hair significantly.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Mogamulizumab can cause hair loss and skin rashes.